INHIBITION OF EDRF RELEASE BY NATIVE LOW-DENSITY-LIPOPROTEIN FROM CULTURED PORCINE ENDOTHELIAL-CELLS THROUGH INTRACELLULAR MECHANISMS

被引:11
作者
EZAKI, M
IKEDA, M
TOMITA, I
TOMITA, T
机构
[1] UNIV SHIZUOKA,GRAD SCH HLTH SCI,SHIZUOKA 422,JAPAN
[2] UNIV SHIZUOKA,SCH PHARMACEUT SCI,SHIZUOKA 422,JAPAN
关键词
LOW-DENSITY LIPOPROTEIN (LDL); OXIDIZED LDL; ENDOTHELIUM-DERIVED RELAXING FACTOR; ENDOTHELIAL CELLS; SMOOTH MUSCLE CELLS; THROMBIN;
D O I
10.1097/00005344-199410000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cyclic GMP accumulation in endothelial cells-smooth muscle cells (EC-SMC) coculture induced by both receptor-dependent (thrombin, bradykinin, BK) and receptor-independent (Ca2+-ionophore A23187) stimulation, was inhibited by preincubation with low-density lipoprotein (LDL) in time- and concentration-dependent manner. At least 5 min was necessary for the complete blockade with LDL (protein 1 mg/ml). LDL did not affect cyclic GMP-increase by sodium nitroprusside (SNP), a direct stimulator of SMC, but oxidized (ox)LDL (50-250 mu g/ml) markedly reduced it. An increase of cyclic GMP accumulation in SMC by eluate from stimulated EC columns was completely blocked by 10-min preincubation of the column with LDL with or without superoxide dismutase (SOD). In contrast, preincubation of the SMC dish with LDL did not affect cyclic GMP accumulation by the eluate from the stimulated EC column, but preincubation with oxLDL (protein 50-100 mu g/ml) greatly reduced it. Exposure time of released EDRF to LDL in both coculture and column experiments was <40-45 s. These results suggest that a brief exposure of EC to pathophysiologic concentration of LDL exclusively affects EC functions, attenuating endothelium-derived relaxing factor (EDRF) release through intracellular mechanisms, and consumption of released EDRF by LDL does not appear to be involved in this LDL inhibitory effect. Possible inhibitory mechanisms of LDL are discussed.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 35 条
  • [1] LOW-DENSITY LIPOPROTEINS INHIBIT ENDOTHELIUM-DEPENDENT RELAXATION IN RABBIT AORTA
    ANDREWS, HE
    BRUCKDORFER, KR
    DUNN, RC
    JACOBS, M
    [J]. NATURE, 1987, 327 (6119) : 237 - 239
  • [2] LOW-DENSITY LIPOPROTEIN CAUSES GENERAL CELLULAR ACTIVATION WITH INCREASED PHOSPHATIDYLINOSITOL TURNOVER AND LIPOPROTEIN CATABOLISM
    BLOCK, LH
    KNORR, M
    VOGT, E
    LOCHER, R
    VETTER, W
    GROSCURTH, P
    QIAO, BY
    POMETTA, D
    JAMES, R
    REGENASS, M
    PLETSCHER, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) : 885 - 889
  • [3] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    GARRISON, RJ
    WILSON, PWF
    ABBOTT, RD
    KALOUSDIAN, S
    KANNEL, WB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2835 - 2838
  • [4] CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN
    ESTERBAUER, H
    STRIEGL, G
    PUHL, H
    ROTHENEDER, M
    [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01): : 67 - 75
  • [5] ENHANCEMENT OF LYSOLECITHIN ACYLTRANSFERASE ACTIVITY BY LDL IN THROMBIN-STIMULATED PORCINE-CULTURED ENDOTHELIAL-CELLS
    EZAKI, M
    INOUE, Y
    TOMITA, I
    TOMITA, T
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1994, 1213 (01): : 75 - 81
  • [6] ATHEROSCLEROSIS OR LIPOPROTEIN-INDUCED ENDOTHELIAL DYSFUNCTION - POTENTIAL MECHANISMS UNDERLYING REDUCTION IN EDRF/NITRIC OXIDE ACTIVITY
    FLAVAHAN, NA
    [J]. CIRCULATION, 1992, 85 (05) : 1927 - 1938
  • [7] FORSTERMANN U, 1986, J PHARMACOL EXP THER, V238, P352
  • [8] FREIDLAND J, 1975, AM J CLIN PATHOL, V66, P416
  • [9] EFFECTS OF NATIVE AND OXIDIZED LOW-DENSITY LIPOPROTEINS ON FORMATION AND INACTIVATION OF ENDOTHELIUM-DERIVED RELAXING FACTOR
    GALLE, J
    MULSCH, A
    BUSSE, R
    BASSENGE, E
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01): : 198 - 203
  • [10] BIOASSAY OF PROSTACYCLIN AND ENDOTHELIUM-DERIVED RELAXING FACTOR (EDRF) FROM PORCINE AORTIC ENDOTHELIAL-CELLS
    GRYGLEWSKI, RJ
    MONCADA, S
    PALMER, RMJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1986, 87 (04) : 685 - 694